The Drug Enforcement Administration today published a direct final rule to clarify that either the purchaser or the supplier may enter a supplier’s DEA registration number on the new single-sheet form that DEA registrants use to order schedule I and II controlled substances. DEA will accept comments on the rule through Aug. 19.

The rule takes effect Oct. 18 unless DEA receives significant adverse comments, in which case it would withdraw the rule by Sept. 20.  

Related News Articles

Perspective
For nearly 20 grueling months, hospitals and health systems — and their steadfast front-line caregivers — have risen to the incredible challenges caused by…
Headline
Rep. Haley Stevens, D-Mich., and Sen. Debbie Stabenow, D-Mich., today introduced a bicameral resolution designating Sept. 17 as National Physician Suicide…
Headline
The House Energy and Commerce and Ways and Means committees yesterday approved their legislative recommendations for the Build Back Better Act, which will be…
Blog
Post-acute care (PAC) providers continue to play a central role in COVID-19 response and recovery. In particular, providers in COVID-19 hotspots have been…
Headline
The House Committee on Energy and Commerce starting Monday will mark up its legislative recommendations for the Build Back Better Act, which will be considered…
Headline
As strongly advocated by the AHA, the Centers for Medicare & Medicaid Services today announced that it is rescinding prior audit denials for hospitals that…